41 related articles for article (PubMed ID: 18393489)
1. Pathophysiological effects of synthetic derivatives of polymeric alkylpyridinium salts from the marine sponge, Reniera sarai.
Grandič M; Frangež R
Mar Drugs; 2014 Apr; 12(5):2408-21. PubMed ID: 24796301
[TBL] [Abstract][Full Text] [Related]
2. Indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources.
Tan Y; Liu M; Li M; Chen Y; Ren M
Front Pharmacol; 2022; 13():1046818. PubMed ID: 36408235
[No Abstract] [Full Text] [Related]
3. Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?
Gibbons WJ; McKinney MG; O'Dell PJ; Bollinger BA; Jones JA
Bioengineered; 2021 Dec; 12(1):8863-8871. PubMed ID: 34607532
[TBL] [Abstract][Full Text] [Related]
4. What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past.
Yao Y; Liang H; Fang X; Zhang S; Xing Z; Shi L; Kuang C; Seliger B; Yang Q
J Exp Clin Cancer Res; 2021 Feb; 40(1):60. PubMed ID: 33557876
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Wang XX; Sun SY; Dong QQ; Wu XX; Tang W; Xing YQ
Medchemcomm; 2019 Oct; 10(10):1740-1754. PubMed ID: 32055299
[TBL] [Abstract][Full Text] [Related]
6. Biologically active marine natural products and their molecular targets discovered using a chemical genetics approach.
Williams DE; Andersen RJ
Nat Prod Rep; 2020 May; 37(5):617-633. PubMed ID: 31750842
[TBL] [Abstract][Full Text] [Related]
7. Major Developments in the Design of Inhibitors along the Kynurenine Pathway.
Jacobs KR; Castellano-Gonzalez G; Guillemin GJ; Lovejoy DB
Curr Med Chem; 2017; 24(23):2471-2495. PubMed ID: 28464785
[TBL] [Abstract][Full Text] [Related]
8. Benzo[b]quinolizinium Derivatives Have a Strong Antimalarial Activity and Inhibit Indoleamine Dioxygenase.
Jortzik E; Zocher K; Isernhagen A; Mailu BM; Rahlfs S; Viola G; Wittlin S; Hunt NH; Ihmels H; Becker K
Antimicrob Agents Chemother; 2016 Jan; 60(1):115-25. PubMed ID: 26459907
[TBL] [Abstract][Full Text] [Related]
9. Trial watch: IDO inhibitors in cancer therapy.
Vacchelli E; Aranda F; Eggermont A; Sautès-Fridman C; Tartour E; Kennedy EP; Platten M; Zitvogel L; Kroemer G; Galluzzi L
Oncoimmunology; 2014 Nov; 3(10):e957994. PubMed ID: 25941578
[TBL] [Abstract][Full Text] [Related]
10. Kynurenines in the CNS: recent advances and new questions.
Vécsei L; Szalárdy L; Fülöp F; Toldi J
Nat Rev Drug Discov; 2013 Jan; 12(1):64-82. PubMed ID: 23237916
[TBL] [Abstract][Full Text] [Related]
11. SHIP-deficient dendritic cells, unlike wild type dendritic cells, suppress T cell proliferation via a nitric oxide-independent mechanism.
Antignano F; Hamilton M; Patterson S; Ho V; Cohen C; Levings MK; Krystal G
PLoS One; 2011; 6(7):e21893. PubMed ID: 21755007
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate.
Muller AJ; DuHadaway JB; Jaller D; Curtis P; Metz R; Prendergast GC
Cancer Res; 2010 Mar; 70(5):1845-53. PubMed ID: 20160032
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory substrate binding site of human indoleamine 2,3-dioxygenase.
Lu C; Lin Y; Yeh SR
J Am Chem Soc; 2009 Sep; 131(36):12866-7. PubMed ID: 19737010
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Löb S; Königsrainer A; Rammensee HG; Opelz G; Terness P
Nat Rev Cancer; 2009 Jun; 9(6):445-52. PubMed ID: 19461669
[TBL] [Abstract][Full Text] [Related]
15. Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.
Kumar S; Jaller D; Patel B; LaLonde JM; DuHadaway JB; Malachowski WP; Prendergast GC; Muller AJ
J Med Chem; 2008 Aug; 51(16):4968-77. PubMed ID: 18665584
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of indoleamine 2,3-dioxygenase inhibitory analogues of the sponge alkaloid exiguamine A.
Carr G; Chung MK; Mauk AG; Andersen RJ
J Med Chem; 2008 May; 51(9):2634-7. PubMed ID: 18393489
[TBL] [Abstract][Full Text] [Related]
17. Exiguamine A, an indoleamine-2,3-dioxygenase (IDO) inhibitor isolated from the marine sponge Neopetrosia exigua.
Brastianos HC; Vottero E; Patrick BO; Van Soest R; Matainaho T; Mauk AG; Andersen RJ
J Am Chem Soc; 2006 Dec; 128(50):16046-7. PubMed ID: 17165752
[TBL] [Abstract][Full Text] [Related]
18. Biomimetic synthesis of the IDO inhibitors exiguamine A and B.
Volgraf M; Lumb JP; Brastianos HC; Carr G; Chung MK; Münzel M; Mauk AG; Andersen RJ; Trauner D
Nat Chem Biol; 2008 Sep; 4(9):535-7. PubMed ID: 18677305
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
